Utility of measuring vitamin B12 and its active fraction, holotranscobalamin, in neurological vitamin B12 deficiency syndromes. (Q51749706)

11 April 2018

title

Utility of measuring vitamin B12 and its active fraction, holotranscobalamin, in neurological vitamin B12 deficiency syndromes. (English)

1 reference

11 April 2018

main subject

vitamin B12 deficiency

0 references

6

Heinz Reichmann

1 reference

11 April 2018

Wiebke Schrempf

1

1 reference

11 April 2018

Marco Eulitz

2

1 reference

11 April 2018

Volker Neumeister

3

1 reference

11 April 2018

Gabriele Siegert

4

1 reference

11 April 2018

Rainer Koch

5

1 reference

11 April 2018

Alexander Storch

7

1 reference

11 April 2018

publication date

2 October 2010

1 reference

11 April 2018

published in

Journal of Neurology

1 reference

11 April 2018

volume

258

1 reference

11 April 2018

issue

3

1 reference

11 April 2018

page(s)

393-401

1 reference

11 April 2018

https://scigraph.springernature.com/pub.10.1007/s00415-010-5764-4

exact match

0 references

cites work

Diagnosis of cobalamin deficiency I: usefulness of serum methylmalonic acid and total homocysteine concentrations

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5764-4

Vitamin B12 (cobalamin) deficiency in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5764-4

Vitamin B12 deficiency in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5764-4

Prevalence of undiagnosed pernicious anemia in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5764-4

Comparison of the deoxyuridine suppression test with serum levels of methylmalonic acid and homocysteine in mild cobalamin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5764-4

Functional vitamin B12 deficiency and determination of holotranscobalamin in populations at risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5764-4

The usefulness of holotranscobalamin in predicting vitamin B12 status in different clinical settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5764-4

Increased plasma methylmalonic acid level does not predict clinical manifestations of vitamin B12 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5764-4

Holotranscobalamin--a first choice assay for diagnosing early vitamin B deficiency?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5764-4

Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5764-4

Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5764-4

Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5764-4

Measurement of total vitamin B12 and holotranscobalamin, singly and in combination, in screening for metabolic vitamin B12 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5764-4

Holotranscobalamin in laboratory diagnosis of cobalamin deficiency compared to total cobalamin and methylmalonic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5764-4

Vitamin B12, folic acid, and the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5764-4

Benefits and risks of folic acid to the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5764-4

Challenges in the identification of cobalamin-deficiency polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5764-4

Neurological complications of acquired cobalamin deficiency: clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5764-4

Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5764-4

Novel and established markers of cobalamin deficiency: complementary or exclusive diagnostic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5764-4

The neuropsychiatry of megaloblastic anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5764-4

Likelihood ratios with confidence: sample size estimation for diagnostic test studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5764-4

Detection of Vitamin B12 Deficiency in Older People by Measuring Vitamin B12 or the Active Fraction of Vitamin B12, Holotranscobalamin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5764-4

Methylmalonic acid measured in plasma and urine by stable-isotope dilution and electrospray tandem mass spectrometry.

21 January 2018

1 reference

12 December 2020

The use of homocysteine and other metabolites in the specific diagnosis of vitamin B-12 deficiency

1 reference

12 December 2020

Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations

1 reference

12 December 2020

Low vitamin B-12 status and risk of cognitive decline in older adults.

1 reference

12 December 2020

Neurologic Aspects of Cobalamin Deficiency

1 reference

12 December 2020

Vitamin B12 deficiency and the fortification of food with folic acid.

1 reference

12 December 2020

Vitamin B(12) and methylmalonic acid levels in patients presenting with polyneuropathy

1 reference

12 December 2020

Reference range and method comparison studies for enzymatic and Jaffé creatinine assays in plasma and serum and early morning urine

1 reference

12 December 2020

Current concepts in the diagnosis of cobalamin deficiency

1 reference

12 December 2020

Measuring and interpreting holo-transcobalamin (holo-transcobalamin II)

1 reference

12 December 2020

Screening elderly populations for cobalamin (vitamin B12) deficiency using the urinary methylmalonic acid assay by gas chromatography mass spectrometry

1 reference

12 December 2020

Prevalence of vitamin B12 deficiency among geriatric outpatients

1 reference

12 December 2020

Direct assay for cobalamin bound to transcobalamin (holo-transcobalamin) in serum

1 reference

12 December 2020

Methylmalonic acid: a test whose time has come?

1 reference

12 December 2020

Metabolic evidence that deficiencies of vitamin B-12 (cobalamin), folate, and vitamin B-6 occur commonly in elderly people

1 reference

12 December 2020

High prevalence of cobalamin deficiency in elderly outpatients

1 reference

12 December 2020

The marker of cobalamin deficiency, plasma methylmalonic acid, correlates to plasma creatinine

1 reference

12 December 2020

Prevalence of cobalamin deficiency in the Framingham elderly population

1 reference

12 December 2020

B12 deficiency and psychiatric disorders: case report and literature review.

1 reference

12 December 2020

10.1007/S00415-010-5764-4

Identifiers

DOI

1 reference

11 April 2018

PubMed ID

20890610

1 reference

11 April 2018